Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Urology Article
This is a selection made from among articles on Drug Treatment Urology. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Alcohol Rehab Treatment
By Damian Murphy
Similar to other illnesses, alcohol addiction can be overcome with increased research efforts, prevention, and proper alcohol addiction treatment.
By providing more people with access to expert alcoholic treatment, the costly drain on society and the physical, psychological, and financial barriers that alcohol addiction places on families can be considerably diminished.
If truth be told, research studies display strong data that effectual alcohol dependency treatment programs and alcohol addiction prevention efforts lead to irrefutable reductions in cancer, hearth disease, child abuse, strokes, traffic fatalities, crime, unwanted pregnancy, HIV, and child abuse.
Special techniques exist for treating alcohol dependency withdrawal. Whereas some of these therapies use medications, scores of, alternatives, do not. Fascinatingly, according to current research findings, the safest way to treat mild withdrawal symptoms is without drugs.
Such non-drug detoxification approaches use wide-extending social support and screening all through the whole withdrawal protocol. Other non-drug detoxification methods, additionally, use vitamin therapy (particularly thiamin) and proper nutrition for treating mild withdrawal symptoms.
Special techniques exist for treating alcohol dependency withdrawal. Whereas some of these therapies use medications, scores of, alternatives, do not. Fascinatingly, according to current research findings, the safest way to treat mild withdrawal symptoms is without drugs.
The following epitomizes mild to moderate physical withdrawal symptoms that usually take place within 6 to 48 hours after the last alcoholic drink:
Looking pale
Involuntary movements of the eyelids
Vomiting
Clammy skin
Vomiting
Enlarged or dilated pupils
Nausea
Rapid heart rate
Pulsating headaches
Tremor of the hands
Sweating (especially on the palms of the hands or on the face)
Loss of appetite
Abnormal movements
Sleeping difficulties
More information on alcohol rehab can be found at www.alcholrehab.com.
Article Source: http://EzineArticles.com/?expert=Damian_Murphy
http://EzineArticles.com/?Alcohol-Rehab-Treatment&id=571317
Drug Treatment Urology Specific links
Drug Treatment Urology News
Novartis Drug Afinitor® Approved By FDA As First Medication To Treat Patients With Non-Cancerous Kidney Tumors ...
Novartis Pharmaceuticals Corporation ("Novartis") announced today that the US Food and Drug Administration (FDA) approved Afinitor® (everolimus) tablets* for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery(2).
Read more...FDA Approves New Impotence Drug Stendra
FRIDAY, April 27 (HealthDay News) -- The U.S. Food and Drug Administration on Friday announced that it had approved Stendra, a new medication for erectile dysfunction.
Read more...Should You Run from that Medical Test? (in Tyee Books)
Alan Cassels, author of 'Seeking Sickness' on the disease screening industry, what it really catches, when to say no, and more.
Read more...Dendreon shares fall after 1Q earnings report
Dendreon Corp. shares sank Tuesday after the drug developer reported a loss and what an analyst described as "modest growth" for the company's only marketed product, the prostate cancer treatment Provenge.
Read more...Auxilium Pharmaceuticals, Inc. Announces XIAFLEX® Peyronie's Phase IIb Study Published In The Journal Of Urology
MALVERN, Pa., May 9, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (AUXL), a specialty biopharmaceutical company, today announced that The Journal of Urology has published on its website, ...
Read more...New Drug To Fight Against Localized High-Risk Prostate Tumors
Men with prostate cancer could significantly benefit from a recently approved hormone-depleting drug, according to results from a phase II clinical trial. The drug - abiraterone acetate (Zytiga(R)) - can help eliminate or almost eliminate tumors in many prostate cancer patients whose cancer has not yet metastasized. The study, conducted by researchers at Dana-Farber Cancer Institute in ...
Read more...FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S.
Read more...Testosterone drug use growing despite risks
Testosterone replacement has long been prescribed for men who suffer from abnormally low levels of the male sex hormone, but overuse can lead to infertility and can even speed the growth of prostate cancer. That hasn't...
Read more...Fast-acting anti-impotence drug could be potential Viagra rival
Washington, May 1 : The U.S. Food and Drug Administration has approved a new erectile dysfunction drug that reportedly works in less than 15 minutes.
Read more...Advanced Soft Tissue Sarcoma, Pazopanib Improves Progression-Free Survival
According to results of the PALETTE trial, treatment with pazopanib increased progression-free survival (PFS) almost three fold among patients with metastatic soft-tissue sarcoma whose disease had progressed following chemotherapy. The results are published Online First in The Lancet. In the United States, an estimated 11,000 individuals are diagnosed with soft-tissue sarcomas each year ...
Read more...